Among those we identified as globally dysregulated in cancer, the medium-chain fatty acid receptor GPR84 was significantly upregulated in fourteen out of the twenty-three cancer types examined, highlighting this receptor as a promising biomarker. The gene discussed is GPR84; the disease is cancer.